Strategies for reporting evidence-based clinical studies involving positron imaging

Clinical Positron Imaging (Netherlands)

Volumn 1, Issue 3, 1998, Pages 175-184

  Papatheofanis, Frank J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Evidence based analysis; Positron emission tomography; Technology assessment

Indexed keywords

EID: 0342551920     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(98)00012-0     Document Type: Article

References (83)

1. F. Mosteller Assessing medical technologies 1985 National Academy Press Washington, DC
2. B.A. Weisbrod The health care quadrilemma an essay on technological change, insurance, quality of care, and cost containment J. Econ. Lit. 29 1991 523 552
3. M. Dietlein K. Scheidhauer E. Voth P. Theissen H. Schicha Fluorine-18fluorodeoxyglucose positron emission tomography and iodine-131 whole body scintigraphy in the follow-up of differentiated thyroid cancer Eu. J. Nucl. Med. 24 1997 1342 1348
4. R.C. Hagberg G.M. Segall P. Stark T.A. Burdon M.F. Pompili Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with fluorodeoxyglucose positron emission tomography Eur. J. Cardio-Thorac. Surg. 12 1997 92 97
5. C. Schiepers Role of positron emission tomography in the staging of lungcancer Lung Cancer 17 Suppl1 1997 S29 S35
6. M.E. Hebert V.J. Lowe J.M. Hoffman E.F. Patz M.S. Anscher Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy preliminary findings Am. J. Clin. Oncol. 19 1996 416 421
7. F. Qing M.J. Hayes C.G. Rhodes Reduced beta adrenoceptor density in vivo in human lung tumours a preliminary study with positron emission tomography Thorax 51 1996 727 732
8. T. Miyauchi R.L. Wahl Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung Eur. J. Nucl. Med. 23 1996 517 523
9. H.J. Jang K.S. Lee O.J. Kwon Bronchioloalveolar carcinoma focal area of ground-glass attenuation at thin-section CT as an early sign Radiology 199 1996 485 488
10. A. Frank D. Lefkowitz S. Jaeger Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings Int. J. Radiat. Oncol. Biol. Phys. 32 1995 1495 1512
11. R.W. Ward R. Chin Jr J.W. Keyes Jr E.F. Haponik Digital clubbing. Demonstration with positron emission tomography Chest 107 1995 1172 1173
12. G.J. Hunter N.C. Choi T.C. McLoud A.J. Fischman Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET J. Nucl. Med. 34 9 1993 1571 1573
13. S.D. Rege C.K. Hoh J.A. Glaspy Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose Cancer 72 1993 82 90
14. K. Kubota S. Yamada K. Ishiwata M. Ito T. Ido Positron emissiontomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer Clin. Nucl. Med. 17 1992 877 881
15. Y. Ichiya Y. Kuwabara M. Otsuka Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography J. Nucl. Med. 32 1991 1655 1660
16. D.M. Goldenberg Perspectives on oncologic imaging with radiolabeledantibodies Cancer 80 1997 2431 2435
17. S. Leskinen M. Lapela P. Lindholm H. Minn Metabolic imaging by positron emission tomography in oncology Ann. Med. 29 1997 271 274
18. N.A. Dewan C.J. Shehan S.D. Reeb Likelihood of malignancy in a solitary pulmonary nodule comparison of Bayesian analysis and results of FDG-PET scan Chest 112 1997 416 422
19. A. Guhlmann M. Storck J. Kotzerke Lymph node staging in non-small cell lung cancer evaluation by [18F]FDG positron emission tomography (PET) Thorax 52 1997 438 441
20. G. Ferlin D. Rubello F. Chierichetti The role of fluorine-18-deoxyglucose (FDG) positron emission tomography (PET) whole body scan (WBS) in the staging and follow-up of cancer patients our first experience Tumori 83 1997 679 684
21. R. Rosell M.P. Lâopez-Cabrerizo J. Astudillo Preoperative chemotherapy for stage IIIA non-small cell lung cancer [see comments] Curr. Opin.Oncol. 9 1997 149 155
22. K.R. Zasadny P.V. Kison L.E. Quint R.L. Wahl Untreated lung cancer quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans Radiology 201 1996 873 876
23. J.S. Rasey W.J. Koh M.L. Evans Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole a pretherapy study of 37 patients Int. J. Radiat. Oncol. Biol. Phys. 36 1996 417 428
24. H. Minn K.R. Zasadny L.E. Quint R.L. Wahl Lung cancer reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucoseuptake at PET Radiology 196 1995 167 173
25. G.W. Boland M.A. Goldberg M.J. Lee Indeterminate adrenal mass in patients with cancer evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 194 1995 131 134
26. V.J. Lowe D.M. DeLong J.M. Hoffman R.E. Coleman Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy Journal of Nuclear Medicine 36 1995 883 887
27. E.F. Patz Jr. V.J. Lowe J.M. Hoffman Persistent or recurrent bronchogenic carcinoma detection with PET and 2-[F-18]-2-deoxy-D-glucose Radiology 191 1994 379 382
28. W.J. Scott L.S. Gobar L.G. Hauser J.J. Sunderland N.A. Dewan J.T. Sugimoto Detection of scalene lymph node metastases from lung cancer. Positron emission tomography Chest 107 1995 1174 1176
29. E.E. Kim S.K. Chung T.P. Haynie Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET Radiographics 12 1992 269 279
30. J. Hatazawa K. Ishiwata M. Itoh Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography Journal of Nuclear Medicine 30 1989 1809 1813
31. H.M. Deloar H. Watabe Y. Hayashi Performance study of a miniature gamma ray scintillation probe for tumor localization Annals of Nuclear Medicine 11 1997 173 181
32. W.J. Koh K.S. Bergman J.S. Rasey Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall call lung cancers using [F-18]fluoromisonidazole positron emission tomography International Journal of Radiation Oncology, Biology, Physics 33 1995 391 398
33. T. Fujiwara T. Matsuzawa K. Kubota Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography Journal of Nuclear Medicine 30 1989 33 37
34. K. Kubota T. Matsuzawa M. Ito Lung tumor imaging by positron emission tomography using C-11 L-methionine Journal of Nuclear Medicine 26 1985 37 42
35. K.S. Lee Y. Kim J. Han Bronchioloalveolar carcinoma clinical, histopathologic, and radiologic findings Radiographics 17 1997 1345 1357
36. Y.E. Erdi O. Mawlawi S.M. Larson Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding Cancer 80 12 Suppl 1997 2505 2509
37. L.S. Broderick R.D. Tarver D.J. Conces Jr Imaging of lung cancer old and new Seminars in Oncology 24 1997 411 418
38. J.J. Erasmus E.F. Patz Jr. H.P. McAdams Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography Ajr. American Journal of Roentgenology 168 1997 1357 1360
39. L.M. Lamki Positron emission tomography, bronchogenic carcinoma, and the adrenals American Journal of Roentgenology 168 5 1997 1361 1362
40. C. Koike M. Watanabe N. Oku Tumor cells with organ-specific metastatic ability show distinctive trafficking in vivo analyses by positron emission tomography and bioimaging Cancer Research 57 1997 3612 3619
41. W.J. Koh K.S. Bergman J.S. Rasey Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography International Journal of Radiation Oncology, Biology, Physics 33 1995 391 398
42. R.L. Wahl L.E. Quint R.D. Cieslak A.M. Aisen R.A. Koeppe C.R. Meyer “Anatometabolic” tumor imaging fusion of FDG PET with CT or MRI to localize foci of increased activity Journal of Nuclear Medicine 34 1997 1190 1197
43. J.A. Glaspy R. Hawkins C.K. Hoh M.E. Phelps Use of positron emission tomography in oncology Oncology 7 7 1993 41 46 49–50
44. M. Tadokoro T. Ota T. Kato K. Ito T. Ishigaki M Amano S. Sakuma Multi-directional positron imaging evaluation of cancer detection with 2-(F-18)-fluoro-2-deoxy-D-glucose Radiation Medicine 10 1992 141 144
45. H.M. Deloar H. Watabe Y. Hayashi Performance study of a miniature gamma ray scintillation vivo probe for tumor localization Annals of Nuclear Medicine 11 1997 173 181
46. P. Lewis S. Griffin P. Marsden Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer Lancet 344 1994 1265
47. T.J. McCarthy C.S. Dence S.W. Holmberg Inhaled [13N]nitric oxide a positron emission tomography (PET) study Nuclear Medicine and Biology 23 1996 773 777
48. A. Schomburg H. Bender C. Reichel Standardized uptake values of fluorine-18 fluorodeoxyglucose the value of different normalization procedures European Journal of Nuclear Medicine 23 1996 571 574
49. G. Larcos M.N. Maisey FDG-PET screening for cerebral metastases in patients with suspected malignancy Nuclear Medicine Communications 17 1996 197 198
50. S.M. Greaves P. Batra High-resolution computed tomography, magnetic resonance imaging, and positron emission tomography in interstitial lung disease Current Opinion in Pulmonary Medicine 1 1995 351 357
51. T. Bury A. Dowlati P. Paulus Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography Eur J Nucl Med 23 1996 204 206
52. T. Bury A. Dowlati P. Paulus Evaluation of the solitary pulmonary nodule by positron emission tomography imaging Eur Respir J 9 1996 410 414
53. T. Bury A. Dowlati P. Paulus Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer Eur Respir J 10 1997 2529 2534
54. R. Chin R. Ward J. Keyes Mediastinal staging of non-small-cell lung cancer with positron emission tomography Am J Respir Crit Care Med 152 1995 2090 2096
55. N.A. Dewan S.D. Reeb N.C. Gupta PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions a comparative risk-benefit analysis Chest 108 1995 441 446
56. F. Duhaylongsod V. Lowe E. Patz Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography Ann Thorac Surg 60 1995 1348 1352
57. F.G. Duhaylongsod V.J. Lowe E.F. Patz Jr Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography [FDG PET] J Thorac Cardiovasc Surg 110 1995 130 140
58. N.C. Gupta A.R. Frank N.A. Dewan Solitary pulmonary nodules detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 184 1992 441 444
59. N. Gupta J. Maloof E. Gunel Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET J Nucl Med 37 1996 943 948
60. K.F. Hubner E. Buonocore H.R. Gould Differentiating benign from malignant lung lesions using quantitative parameters of FDG PET images Clin Nucl Med 21 1996 941 949
61. K.F. Hubner E. Buonocore S.K. Singh Characterization of chest masses by FDG positron emission tomography Clin Nucl Med 20 1995 293 298
62. S. Knight D. Delbeke J. Stewart Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy Chest 109 1996 982 988
63. K. Kubota T. Matsuzawa T. Fujiwara Differential diagnosis of lung tumor with positron emission tomography A prospective study J Nucl Med 31 1990 1927 1933
64. V.J. Lowe F.G. Duhaylongsod E.F. Patz Pulmonary abnormalities and PET data analysis A retrospective study Radiology 202 1997 435 439
65. V.J. Lowe J.W. Fletcher L. Gobar Prospective investigation of positron emission tomography in lung nodules Journal of Clinical Oncology 16 1998 1075 1084
66. V.J. Lowe J.M. Hoffman D.M. DeLong Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities J Nucl Med 35 1994 1771 1776
67. E.F. Patz V.J. Lowe P. Goodman Thoracic nodal staging with PET imaging with FDG in patients with bronchogenic carcinoma Chest 108 1995 1617 1621
68. E.F. Patz V.J. Lowe J.M. Hoffman Focal pulmonary abnormalities Evaluation with F-18 fluorodeoxyglucose PET scanning Radiology 188 1993 487 490
69. M. Sasaki Y. Ichiya Y. Kuwabara The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non small cell lung cancer a comparative study with x-ray computed tomography Eur J Nucl Med 23 1996 741 747
70. D. Sazon S. Santiago G. Soo Hoo Fluorodeoxyglucose-Positron emission tomography in the detection and staging of lung cancer Am J Respir Crit Car Med 153 1996 417 421
71. W. Scott L. Gobar J. Terry Mediastinal lymph node staging of non small cell lung cancer a prospective comparison of computed tomography and positron emission tomography J Thorac Cardiovasc Surg 111 1996 642 648
72. W.J. Scott J.L. Schwabe N.C. Gupta Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F] fluorodeoxyglucose Ann Thorac Surg 58 1994 698 703
73. D.O. Slosman A. Spiliopoulos F. Couson Satellite PET and lung cancer A prospective study in surgical patients Nucl Med Commun 14 1993 955 961
74. H.C. Steinert R.A.H. Boni A. Buck Malignant melanoma Staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose Radiology 195 1995 705 709
75. P.E. Valk T.R. Pounds D.M. Hopkins Staging non-small cell lung cancer by whole-body positron emission tomographic imaging Ann Thorac Surg 60 1995 1573 1582
76. J.F. Vansteenkiste S.G. Stroobants P.R. De Leyn Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer a prospective analysis of 50 cases Leuven Lung Cancer Group. Chest 112 1997 1480 1486
77. R.L. Wahl L.E. Quint R.L. Greenough Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images Preliminary prospective evaluation Radiology 191 1994 371 377
78. S. Gleeson Blue cross and blue shield association initiatives in technology assessment A.C. Gelijns H.V. Dawkins Adopting New Medical Technology 1994 National Academy Press Washington, DC
79. P.D. Lairson Kaiser permanente’s new technology committee coverage decisionmaking in s group model health maintenance organization A.C. Gelijns H.V. Dawkins Adopting New Medical Technology 1994 National Academy Press Washington, DC
80. K.A. Buto Decisionmaking in the health care finance administration A.C. Gelijns H.V. Dawkins Adopting New Medical Technology 1994 National Academy Press Washington, DC
81. J.H. Zar Biostatistical Analysis [3rd edition] 1996 Prentice Hall Upper Saddle River
82. S.S. Gambhir J.E. Shepherd B.D. Shah Analytical decision model for the cost-effective management of solitary pulmonary nodules Journal of Clinical Oncology 16 1998 2113 2125
83. S.S. Gambhir C.K. Hoh M.E. Phelps I. Madar J. Maddahi Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma Journal of Nuclear Medicine 37 1996 1428 1436